AFFINITTX.COM KEYWORD DENSITY CHECKER

Total words: 743 | 2-word phrases: 186 | 3-word phrases: 206 | 4-word phrases: 217

PAGE INFO

Title Try to keep the title under 60 characters (54 characters)
Affini-T Therapeutics | Unlocking the power of T cells
Description Try to keep the meta description between 50 - 160 characters (151 characters)
Affini-T Therapeutics to Present Novel CRISPR Gene Editing Data from its Oncogenic Driver Program Targeting KRAS and Unlocking the Power of T cells ...
Keywords Meta keywords are not recommended anymore (0 characters)
H1 H1 tag on the page (14 characters)
Right Targets.

ONE WORD PHRASES 134 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1affinit75.22%
2and64.48%
3therapeutics64.48%
4the64.48%
5t53.73%
6releases53.73%
7press53.73%
8of53.73%
9affini42.99%
10american42.99%

TWO WORD PHRASES 186 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1affinit therapeutics63.23%
2press releases52.69%
3affini t42.15%
4annual meeting42.15%
5at the42.15%
6targeting kras31.61%
7kras g12d31.61%
8g12d and31.61%
9the american31.61%
10p53 r175h31.61%
11from its31.61%
12data from31.61%
13forge road21.08%
14for cancer21.08%
15to present21.08%
16t cells21.08%
17of t21.08%
18therapeutics inc21.08%
19therapeutics to21.08%
202024 affinit21.08%

THREE WORD PHRASES 206 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1targeting kras g12d31.46%
2at the american31.46%
3kras g12d and31.46%
4data from its31.46%
5r175h at the20.97%
6therapeutics to present20.97%
7affinit therapeutics to20.97%
8preclinical data from20.97%
9g12d and p5320.97%
10and p53 r175h20.97%
11p53 r175h at20.97%
12association for cancer20.97%
13for cancer research20.97%
14research aacr annual20.97%
15aacr annual meeting20.97%
16cancer research aacr20.97%
172024 affinit therapeutics20.97%
18affinit therapeutics inc20.97%
19© 2024 affinit20.97%
20100 forge road20.97%
21watertown ma 0247220.97%
22presentation of trialinprogress10.49%
23of clinical oncology10.49%
24announces first patient10.49%
25from its preclinical10.49%
26present data from10.49%
27to present data10.49%
28first patient dosed10.49%
292024 annual meeting10.49%
30asco 2024 annual10.49%

FOUR WORD PHRASES 217 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1targeting kras g12d and31.38%
2for cancer research aacr20.92%
3affinit therapeutics to present20.92%
4association for cancer research20.92%
5cancer research aacr annual20.92%
6research aacr annual meeting20.92%
7kras g12d and p5320.92%
8preclinical data from its20.92%
9p53 r175h at the20.92%
10g12d and p53 r175h20.92%
11r175h at the american20.92%
12© 2024 affinit therapeutics20.92%
132024 affinit therapeutics inc20.92%
14therapeutics to present data10.46%
15to present data from10.46%
16oncology asco 2024 annual10.46%
17present data from its10.46%
18clinical oncology asco 202410.46%
19of clinical oncology asco10.46%
20data from its preclinical10.46%
21from its preclinical programs10.46%
22asco 2024 annual meeting10.46%
23affini t primary logo10.46%
24t primary logo gradient10.46%
25the american society of10.46%
26at the american society10.46%
27poster at the american10.46%
28trialinprogress poster at the10.46%
29of trialinprogress poster at10.46%
30presentation of trialinprogress poster10.46%
31and presentation of trialinprogress10.46%
32program and presentation of10.46%
331 program and presentation10.46%
34in kras g12v phase10.46%
35dosed in kras g12v10.46%
36patient dosed in kras10.46%
37first patient dosed in10.46%
38announces first patient dosed10.46%
39programs targeting kras g12d10.46%
40cell therapy asgct 27th10.46%

EXTERNAL LINKS

# URL Whois Check